RobertGabrielSternMD(He/Him)

PubMed

• 9 citations
  Valproic Acid Induced Hyperammonemia in a Long Time Treated Patient
  Rohit Aiyer, Margaret Seide, Robert G. Stern> ;Case Reports in Psychiatry. 2016 Jul 19
• 34 citations
  Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia.
  Richard S.E. Keefe, George M. Haig, Stephen R. Marder, Philip D. Harvey, Eduardo Dunayevich, Alice Medalia, Michael Davidson, Ilise Lombardo, Christopher R. Bowie, Rob...> ;Schizophrenia Bulletin. 2015 Sep 11
• 6 citations
  Clozapine-induced sialorrhea alleviated by bupropion--a case report.
  Robert G. Stern, Dona Bellucci, Nancy Cursi-Vogel, Jamila Hughley, Natarajan Elangovan> ;Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2009 Nov 13
• Aripiprazole for the treatment of schizophrenia with co-occurring social anxiety: an open-label cross-taper study.
  Stern, R. G.,Petti, T. A.,Bopp, K.,Tobia, A.> ;J Clin Psychopharmacol. 2009 May 15
• 110 citations
  A program for managing weight gain associated with atypical antipsychotics.
  Betty Vreeland, Shula Minsky, Matthew Menza, Diane Rigassio Radler, Beatrix Roemheld-Hamm, Robert G. Stern> ;Psychiatric Services. 2003 Aug 1
• 52 citations
  The Efficacy and Safety of Clozapine Versus Chlorpromazine in Geriatric Schizophrenia
  E. Howanitz, M Pardo, David A. Smelson, Charles Engelhart, Norman Eisenstein, R G Stern, Miklos F. Losonczy> ;The Journal of Clinical Psychiatry. 1999 Jan 31
• 4 citations
  COMPUTERIZED SELF-ASSESSMENT OF PSYCHOSIS SEVERITY QUESTIONNAIRE COSAPSQ IN SCHIZOPHRENIA : PRELIMINARY RESULTS
  Stern Rg, Fudge R, Cecile E. Sison, E. R. Allan, Crichton J, Miklos F. Losonczy> ;Psychopharmacology Bulletin. 1998 Jan 1
• 21 citations
  Limitations of controlled augmentation trials in schizophrenia
  Robert G. Stern, James Schmeidler, Michael Davidson> ;Biological Psychiatry. 1997 Jul 15
• Assessment of the central dopaminergic index of plasma HVA in schizophrenia.
  Amin F, Davidson M, Kahn RS, Schmeidler J, Stern R, Knott PJ, Apter S> ;Schizophr Bull. 1995-01-01
• 23 citations
  Early response to clozapine in schizophrenia.
  Robert G. Stern, R.S. Kahn, Michael H. Davidson, Rena M. Nora, Kenneth L. Davis> ;The American Journal of Psychiatry. 1994 Dec 1
• 325 citations
  A longitudinal study of Alzheimer's disease : measurement, rate, and predictors of cognitive deterioration
  Robert G. Stern, Richard C. Mohs, Michael Davidson, James Schmeidler, Jeremy M. Silverman, Elise Kramer-Ginsberg, Terena Searcey, Linda M. Bierer, Kenneth L. Davis> ;The American Journal of Psychiatry. 1994 Mar 1
• 45 citations
  Effect of Neuroleptic Medication on Cerebrospinal Fluid Monoamine Metabolite Concentrations in Schizophrenia: Serotonin-Dopamine Interactions as a Target for Treatment
  Rent S. Kahn, Michael H. Davidson, P. Knott, Robert G. Stern, Seth Apter, Kenneth L. Davis> ;Archives of General Psychiatry. 1993 Aug 1
• 25 citations
  Early response to haloperidol treatment in chronic schizophrenia
  Robert G. Stern, R.S. Kahn, Philip D. Harvey, Farooq Amin, Seth Apter, Jack Hirschowitz> ;Schizophrenia Research. 1993 Aug 1
• 23 citations
  Predictors of Response to Neuroleptic Treatment in Schizophrenia
  Robert G. Stern, R.S. Kahn, Michael Davidson> ;The Psychiatric Clinics of North America. 1993 Jun 1
• 37 citations
  Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia
  Michael Davidson, R.S. Kahn, Robert G. Stern, Jack Hirschowitz, Seth Apter, P. Knott, Kenneth L. Davis> ;Psychiatry Research. 1993 Feb 1
• 11 citations
  A pilot study of oral physostigmine plus yohimbine in patients with Alzheimer disease.
  Linda M. Bierer, Paul S. Aisen, Michael H. Davidson, Theresa M. Ryan, Robert G. Stern, James Schmeidler, Kenneth L. Davis> ;Alzheimer Disease and Associated Disorders. 1993 Jan 1
• 36 citations
  Serotonin function in schizophrenia: Effects of meta- chlorophenylpiperazine in schizophrenia patients and healthy subjects
  R.S. Kahn, Larry J. Siever, Steven M. Gabriel, Farooq Amin, Robert G. Stern, K. Dumont, Seth Apter, Michael Davidson> ;Psychiatry Research. 1992 Jul 1
• 33 citations
  Deterioration on the blessed test in Alzheimer's disease: Longitudinal data and their implications for clinical trials and identification of subtypes
  Robert G. Stern, Richard C. Mohs, Linda M. Bierer, Jeremy M. Silverman, James Schmeidler, Michael Davidson, Kenneth L. Davis> ;Psychiatry Research. 1992 May 1
• 13 citations
  Nocturnal growth hormone secretion in schizophrenic patients and healthy subjects
  René S. Kahn, Michael Davidson, Jack Hirschowitz, Robert G. Stern, Bonnie M. David, S. Gabriel, Clare Moore, Kenneth L. Davis> ;Psychiatry Research. 1992 Feb 1
• 1 citations
  Measurements of plasma homovanillic acid in schizophrenic patients.
  Michael Davidson, René S. Kahn, Robert G. Stern, Philip D. Harvey, Richard S.E. Keefe, P. Knott, Seth Apter, L. Webster, Kenneth L. Davis> ;Clinical Neuropharmacology. 1992 Jan 1
• 15 citations
  Cholinergic strategies in the treatment of Alzheimer's disease.
  Michael Davidson, Robert G. Stern, Linda M. Bierer, Thomas B. Horvath, Z.v.i. Zemishlani, R. Markofsky, Richard C. Mohs> ;Acta Psychiatrica Scandinavica. Supplementum. 1991 Sep 1
• 12 citations
  The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach.
  Michael Davidson, Robert G. Stern> ;The Psychiatric Clinics of North America. 1991 Jun 1
• 21 citations
  The use of benzodiazepines in the management of behavioral symptoms in demented patients.
  Robert G. Stern, Michelle E. Duffelmeyer, Z.v.i. Zemishlani, Michael Davidson> ;The Psychiatric Clinics of North America. 1991 Jun 1
• 17 citations
  Diagnostic and Pharmacological Approaches in Alzheimer’s Disease
  Carol Hermann, Robert G. Stern, Miklos F. Losonzcy, Stacey Jaff, Michael Davidson> ;Drugs & Aging. 1991 Mar 1
• Join now to see all